Content about Warfarin

April 30, 2013
FDA approves anticoagulant-reversal product

The Food and Drug Administration has approved a drug that reverses the effects of anticoagulant drugs in patients who have suffered acute major bleeding, the agency said.

January 2, 2013
FDA approves Bristol-Myers Squibb's Eliquis to reduce risk of stroke, blood clots

The Food and Drug Administration last week approved the anti-clotting drug Eliquis (apixaban), an oral tablet used to reduce the risk of stroke and dangerous blood clots in patients with atrial fibrillation that is not caused by a heart valve problem. Eliquis is manufactured by Bristol-Myers Squibb, and marketed by BMS and Pfizer.

November 8, 2012
Study: Aspirin effective in preventing clots following joint replacement surgery

Recent research from the Rothman Institute at Jefferson has shown aspirin to be just as effective in preventing clots — specifically pulmonary emboli, life-threatening blood clots that can develop in the arteries of the lungs following joint replacement surgery — Thomas Jefferson University announced Wednesday.

March 26, 2012
Sunpeaks Ventures debuts TV spot for blood-thinner-friendly multivitamin

Sunpeaks Ventures last week announced national advertising support behind its Clotamin multivitamin line — a line of supplements formulated for use by patients on warfarin or other blood thinners.

August 29, 2011
Pfizer, BMS drug more effective than warfarin in AF patients

A drug made by Pfizer and Bristol-Myers Squibb undergoing late-stage clinical trials was more effective than the generic drug warfarin in patients with atrial fibrillation, according to study results released Sunday.

February 14, 2011
Study: Bristol's apixaban effective among atrial fibrillation patients

An investigational drug made by Bristol-Myers Squibb works better than aspirin in reducing the risk of complications in certain patients with heart rhythm problems, according to results of a late-stage clinical trial published in the New England Journal of Medicine.

November 14, 2010
J&J announces results of phase-3 trial of rivaroxaban

An investigational drug made by Johnson & Johnson is more effective in reducing the risk...

September 20, 2010
FDA advisory committee recommends approval of BI's atrial fibrillation drug

A Food and Drug Administration advisory committee has recommended approval of a drug for patients...

March 17, 2010
Merck, Portola release results of mid-stage betrixaban trial

An investigational pill reduced bleeding in patients with atrial fibrillation better than a widely available...

© 2013 Drug Store News. All Rights Reserved.